Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation

References

• Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr. 1984;4(1):409–454.
   PubMedGoogle Scholar
• Davis TA, Fiorotto ML, Reeds PJ. Amino acid compositions of body and milk protein change during the suckling period in rats. J Nutr. 1993;123(5):947–956.
   PubMed Web of Science ®Google Scholar
• Moura A, Savageau MA, Alves R. Relative amino acid composition signatures of organisms and environments. PLoS One. 2013;8(10):e77319.
   PubMed Web of Science ®Google Scholar
• Adeva-Andany MM, López-Maside L, Donapetry-García C, Fernández-Fernández C, Sixto-Leal C. Enzymes involved in branched-chain amino acid metabolism in humans. Amino Acids. 2017;49(6):1005–1028.
   PubMed Web of Science ®Google Scholar
• Supruniuk E, Żebrowska E, Chabowski A. Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? Crit Rev Food Sci Nutr. 2023;63(15):2559–2597.
   PubMed Web of Science ®Google Scholar
• Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E, Rasmussen BB. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010;298(5):E1011–1018.
   PubMed Web of Science ®Google Scholar
• Hyde R, Taylor PM, Hundal HS. Amino acid transporters: roles in amino acid sensing and signalling in animal cells. Biochem J. 2003;373(Pt 1):1–18.
   PubMedGoogle Scholar
• Yoshizawa F. New therapeutic strategy for amino acid medicine: notable functions of branched chain amino acids as biological regulators. J Pharmacol Sci. 2012;118(2):149–155.
   PubMed Web of Science ®Google Scholar
• Brosnan ME, Lowry A, Wasi Y, Lowry M, Brosnan JT. Regional and subcellular distribution of enzymes of branched-chain amino acid metabolism in brains of normal and diabetic rats. Can J Physiol Pharmacol. 1985;63(10):1234–1238.
   PubMed Web of Science ®Google Scholar
• Brautigam CA, Wynn RM, Chuang JL, Machius M, Tomchick DR, Chuang DT. Structural insight into interactions between dihydrolipoamide dehydrogenase (e3) and e3 binding protein of human pyruvate dehydrogenase complex. Structure. 2006;14(3):611–621.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA. Site-directed mutagenesis of phosphorylation sites of the branched chain alpha-ketoacid dehydrogenase complex. J Biol Chem. 1994;269(28):18583–18587.
   PubMed Web of Science ®Google Scholar
• Wynn RM, Kato M, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT. Molecular mechanism for regulation of the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex by phosphorylation. Structure. 2004;12(12):2185–2196.
   PubMed Web of Science ®Google Scholar
• Lu G, Sun H, She P, Youn J-Y, Warburton S, Ping P, Vondriska TM, Cai H, Lynch CJ, Wang Y, et al. Protein phosphatase 2cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest. 2009;119(6):1678–1687.
   PubMed Web of Science ®Google Scholar
• Qian L, Li N, Lu X-C, Xu M, Liu Y, Li K, Zhang Y, Hu K, Qi Y-T, Yao J, et al. Enhanced bcat1 activity and BCAA metabolism promotes RHOC activity in cancer progression. Nat Metab. 2023;5(7):1159–1173.
   PubMedGoogle Scholar
• East MP, Laitinen T, Asquith CRM. BCKDK: an emerging kinase target for metabolic diseases and cancer. Nat Rev Drug Discov. 2021;20(7):498–498.
   PubMed Web of Science ®Google Scholar
• Du C, Liu W-J, Yang J, Zhao S-S, Liu H-X. The role of branched-chain amino acids and branched-chain α-keto acid dehydrogenase kinase in metabolic disorders. Front Nutr. 2022; 9:932670.
   PubMed Web of Science ®Google Scholar
• Sivanand S, Vander Heiden MG. Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell. 2020;37(2):147–156.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Shanmugalingam U, Smith PD. Potential roles of branched-chain amino acids in neurodegeneration. Nutrition. 2022; 103-104:111762.
   PubMed Web of Science ®Google Scholar
• Novarino G, El-Fishawy P, Kayserili H, Meguid NA, Scott EM, Schroth J, Silhavy JL, Kara M, Khalil RO, Ben-Omran T, et al. Mutations in bckd-kinase lead to a potentially treatable form of autism with epilepsy. Science. 2012;338(6105):394–397.
   PubMed Web of Science ®Google Scholar
• Maynard TM, Manzini MC. Balancing act: maintaining amino acid levels in the autistic brain. Neuron. 2017;93(3):476–479.
   PubMed Web of Science ®Google Scholar
• Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer’s disease and other metabolic disorders. Neural Regen Res. 2020;15(8):1460–1470.
   PubMed Web of Science ®Google Scholar
• Cole JT, Mitala CM, Kundu S, Verma A, Elkind JA, Nissim I, Cohen AS. Dietary branched chain amino acids ameliorate injury-induced cognitive impairment. Proc Natl Acad Sci U S A. 2010;107(1):366–371.
   PubMed Web of Science ®Google Scholar
• Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10(12):723–736.
   PubMed Web of Science ®Google Scholar
• Zhou M, Shao J, Wu C-Y, Shu L, Dong W, Liu Y, Chen M, Wynn RM, Wang J, Wang J, et al. Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes. 2019;68(9):1730–1746.
   PubMed Web of Science ®Google Scholar
• Chen T, Ni Y, Ma X, Bao Y, Liu J, Huang F, Hu C, Xie G, Zhao A, Jia W, et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci Rep. 2016;6(1):20594.
   PubMedGoogle Scholar
• Tai ES, Tan MLS, Stevens RD, Low YL, Muehlbauer MJ, Goh DLM, Ilkayeva OR, Wenner BR, Bain JR, Lee JJM, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia. 2010;53(4):757–767.
   PubMed Web of Science ®Google Scholar
• Biswas D, Dao KT, Mercer A, Cowie AM, Duffley L, El Hiani Y, Kienesberger PC, Pulinilkunnil T. Branched-chain ketoacid overload inhibits insulin action in the muscle. J Biol Chem. 2020;295(46):15597–15621.
   PubMed Web of Science ®Google Scholar
• Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr. 2005;82(2):355–365.
   PubMed Web of Science ®Google Scholar
• Kadota Y, Toyoda T, Kitaura Y, Adams SH, Shimomura Y. Regulation of hepatic branched-chain α-ketoacid dehydrogenase complex in rats fed a high-fat diet. Obes Res Clin Pract. 2013;7(6):e439–444.
   PubMed Web of Science ®Google Scholar
• She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab. 2007;293(6):E1552–1563.
   PubMed Web of Science ®Google Scholar
• Yu D, Moore SC, Matthews CE, Xiang Y-B, Zhang X, Gao Y-T, Zheng W, Shu X-O. Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults. Metabolomics. 2016;12(1):3.
   PubMed Web of Science ®Google Scholar
• Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, Fritsche A, Häring H-U, Hrabě de Angelis M, Peters A, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–648.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang F, Xia Y, Zhao S, Yan W, Wang H, Lee Y, Li C, Zhang L, Lian K, et al. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol. 2016;311(5):H1160–h1169.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhou M, Sun H, Wang Y. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res. 2011;90(2):220–223.
   PubMed Web of Science ®Google Scholar
• Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem. 2012;58(1):139–147.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Granger CB, Craig D, Haynes C, Bain J, Stevens RD, Hauser ER, Newgard CB, Kraus WE, Newby LK, et al. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis. 2014;232(1):191–196.
   PubMed Web of Science ®Google Scholar
• Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P, Roth E, Fürnsinn C, Promintzer M, Anderwald C, et al. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes. 2007;56(6):1600–1607.
   PubMed Web of Science ®Google Scholar
• Ong PS, Wang LZ, Dai X, Tseng SH, Loo SJ, Sethi G. Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives. Front Pharmacol. 2016; 7:395.
   PubMed Web of Science ®Google Scholar
• Katagiri R, Goto A, Nakagawa T, Nishiumi S, Kobayashi T, Hidaka A, Budhathoki S, Yamaji T, Sawada N, Shimazu T, et al. Increased levels of branched-chain amino acid associated with increased risk of pancreatic cancer in a prospective case-control study of a large cohort. Gastroenterology. 2018;155(5):1474–1482.e1471.
   PubMed Web of Science ®Google Scholar
• Ericksen RE, Lim SL, McDonnell E, Shuen WH, Vadiveloo M, White PJ, Ding Z, Kwok R, Lee P, Radda GK, et al. Loss of BCAA catabolism during carcinogenesis enhances mtorc1 activity and promotes tumor development and progression. Cell Metab. 2019;29(5):1151–1165.e1156.
   PubMed Web of Science ®Google Scholar
• Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019;18(1):86.
   PubMedGoogle Scholar
• Oyarzabal A, Bravo-Alonso I, Sánchez-Aragó M, Rejas MT, Merinero B, García-Cazorla A, Artuch R, Ugarte M, Rodríguez-Pombo P. Mitochondrial response to the BCKDK-deficiency: some clues to understand the positive dietary response in this form of autism. Biochim Biophys Acta. 2016;1862(4):592–600.
   PubMed Web of Science ®Google Scholar
• Xue P, Zeng F, Duan Q, Xiao J, Liu L, Yuan P, Fan L, Sun H, Malyarenko OS, Lu H, et al. BCKDK of BCAA catabolism cross-talking with the MAPK pathway promotes tumorigenesis of colorectal cancer. EBioMedicine. 2017; 20:50–60.
   PubMed Web of Science ®Google Scholar
• Tso S-C, Qi X, Gui W-J, Chuang JL, Morlock LK, Wallace AL, Ahmed K, Laxman S, Campeau PM, Lee BH, et al. Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase. Proc Natl Acad Sci U S A. 2013;110(24):9728–9733.
   PubMed Web of Science ®Google Scholar
• Tso S-C, Gui W-J, Wu C-Y, Chuang JL, Qi X, Skvora KJ, Dork K, Wallace AL, Morlock LK, Lee BH, et al. Benzothiophene carboxylate derivatives as novel allosteric inhibitors of branched-chain α-ketoacid dehydrogenase kinase. J Biol Chem. 2014;289(30):20583–20593.
   PubMed Web of Science ®Google Scholar
• Friberg A, Vigil D, Zhao B, Daniels RN, Burke JP, Garcia-Barrantes PM, Camper D, Chauder BA, Lee T, Olejniczak ET, et al. Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. J Med Chem. 2013;56(1):15–30.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3–26.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–341.
   PubMedGoogle Scholar
• Brunetti-Pierri N, Lanpher B, Erez A, Ananieva EA, Islam M, Marini JC, Sun Q, Yu C, Hegde M, Li J, et al. Phenylbutyrate therapy for maple syrup urine disease. Hum Mol Genet. 2011;20(4):631–640.
   PubMed Web of Science ®Google Scholar
• Lyu J, Wang S, Balius TE, Singh I, Levit A, Moroz YS, O'Meara MJ, Che T, Algaa E, Tolmachova K, et al. Ultra-large library docking for discovering new chemotypes. Nature. 2019;566(7743):224–229.
   PubMed Web of Science ®Google Scholar
• Gorgulla C, Boeszoermenyi A, Wang Z-F, Fischer PD, Coote PW, Padmanabha Das KM, Malets YS, Radchenko DS, Moroz YS, Scott DA, et al. An open-source drug discovery platform enables ultra-large virtual screens. Nature. 2020;580(7805):663–668.
   PubMed Web of Science ®Google Scholar
• Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15(5):606–614.
   PubMed Web of Science ®Google Scholar
• Kujala UM, Peltonen M, Laine MK, Kaprio J, Heinonen OJ, Sundvall J, Eriksson JG, Jula A, Sarna S, Kainulainen H, et al. Branched-chain amino acid levels are related with surrogates of disturbed lipid metabolism among older men. Front Med. 2016; 3:57.
   Web of Science ®Google Scholar
• Lee JH, Cho Y-R, Kim JH, Kim J, Nam HY, Kim SW, Son J. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Exp Mol Med. 2019;51(11):1–11.
   Google Scholar
• Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169(2):361–371.
   PubMed Web of Science ®Google Scholar
• Jewell JL, Russell RC, Guan KL. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol. 2013;14(3):133–139.
   PubMed Web of Science ®Google Scholar
• Kim D-H, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110(2):163–175.
   PubMed Web of Science ®Google Scholar
• Kanazawa T, Taneike I, Akaishi R, Yoshizawa F, Furuya N, Fujimura S, Kadowaki M. Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem. 2004;279(9):8452–8459.
   PubMed Web of Science ®Google Scholar
• Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406.
   PubMed Web of Science ®Google Scholar
• Yoshizawa F. Regulation of protein synthesis by branched-chain amino acids in vivo. Biochem Biophys Res Commun. 2004;313(2):417–422.
   PubMed Web of Science ®Google Scholar
• Eley HL, Russell ST, Tisdale MJ. Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochem J. 2007;407(1):113–120.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang S, Hu Q, Gao S, Ma X, Zhang W, Shen Y, Chen F, Lai L, Pei J, et al. Cavityplus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res. 2018;46(W1):W374–w379.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Pei J, Lai L. Binding site detection and druggability prediction of protein targets for structure-based drug design. Curr Pharm Des. 2013;19(12):2326–2333.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Pei J, Lai L. Ligbuilder 2: a practical de novo drug design approach. J Chem Inf Model. 2011;51(5):1083–1091.
   PubMed Web of Science ®Google Scholar
• Xie J, Wang S, Xu Y, Deng M, Lai L. Uncovering the dominant motion modes of allosteric regulation improves allosteric site prediction. J Chem Inf Model. 2022;62(1):187–195.
   PubMed Web of Science ®Google Scholar
• Ma X, Meng H, Lai L. Motions of allosteric and orthosteric ligand-binding sites in proteins are highly correlated. J Chem Inf Model. 2016;56(9):1725–1733.
   PubMed Web of Science ®Google Scholar
• Gorgulla C, Fackeldey K, Wagner G, et al. Accounting of receptor flexibility in ultra-large virtual screens with virtual flow using a grey wolf optimization method. Supercomput Front Innovat. 2020; 7:4–12.
   PubMedGoogle Scholar
• Gorgulla C, Çınaroğlu SS, Fischer PD, Fackeldey K, Wagner G, Arthanari H. Virtualflow ants-ultra-large virtual screenings with artificial intelligence driven docking algorithm based on ant colony optimization. Int J Mol Sci. 2021;22(11):5807.
   PubMed Web of Science ®Google Scholar